Litigation is the Pits – Claim Dismissed for Injuries Caused by Natural Food Substance

January 25, 2019
/
FDA General Litigation Off Label Product Liability
/

“A lady bit down on a pit in an olive …” may sound like the opening line to a bad joke, but the defendant she sued for her injuries with the help of an injury lawyer from https://www.braininjurylawyersorangecounty.com/ appears to have had the last laugh. The plaintiff filed a personal injury claim with the help of a personal injury attorney from www.kwdllp.com/workplace-accidents/ against the defendant in California state court for products liability and pursued theories of strict liability, negligence and breach of an express written…
Continue reading...

Which Gate Do I Enter? Expert Admissibility Standards Far From Uniform

H. Lockwood Miller III

In August, the New Jersey Supreme Court released its opinion in In Re: Accutane Litigation, which as fans of expert-admissibility standards will know essentially moved New Jersey into the column of states that apply a Daubert-based test, rather an a Frye-based test, in evaluating the admissibility of scientific and expert testimony. For anyone who has not yet seen the opinion, a copy can be found here. (Note – it is lengthy, so get a full cup of coffee before you sit…
Continue reading...

Daily Changes Across the Cannabis Legal Landscape

October 1, 2018
/
Cannabis Law Litigation Medical Marijuana
/

Adam R. Dolan

At this point, it should be no surprise to anyone that on a daily basis, the legal landscape of Cannabis law changes and this gives companies like Magnolia Wellness to come up with products involving cannabis extracts which benefits people in a significant way. Zoning issues, licensing and potential medical conditions that can utilize cannabis for treatment are just some of the areas that face consistent legal scrutiny. Below are just a few examples of some of the changes that have occurred in various states…
Continue reading...

Superior Court of Pennsylvania Issues Ruling Addressing Multiple Issues in Pharmaceutical Case

Sean T. Stadelman

In an opinion filed January 8, 2018, Pennsylvania’s intermediate appellate court addressed multiple issues arising after a plaintiff’s verdict in a case